share_log

Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(0.0%),VHCP Co-Investment Holdings III, LLC(0.0%), etc.

SEC announcement ·  Feb 15 10:18
Summary by Futu AI
A group of entities and individuals, including Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah, and Bong Koh, have filed an amended Schedule 13G/A with the SEC, indicating they no longer beneficially own more than five percent of Avalo Therapeutics, Inc.'s common stock as of December 31, 2023. The filing, dated February 14, 2024, confirms that each reporting person within the group holds zero shares and has zero percent ownership of the class, signifying a complete divestment from Avalo Therapeutics. The entities and individuals are primarily organized under the laws of Delaware, with Shah and Koh being United States citizens. The filing ensures that the disposition of the shares is not for the purpose of changing or influencing the control of Avalo Therapeutics.
A group of entities and individuals, including Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah, and Bong Koh, have filed an amended Schedule 13G/A with the SEC, indicating they no longer beneficially own more than five percent of Avalo Therapeutics, Inc.'s common stock as of December 31, 2023. The filing, dated February 14, 2024, confirms that each reporting person within the group holds zero shares and has zero percent ownership of the class, signifying a complete divestment from Avalo Therapeutics. The entities and individuals are primarily organized under the laws of Delaware, with Shah and Koh being United States citizens. The filing ensures that the disposition of the shares is not for the purpose of changing or influencing the control of Avalo Therapeutics.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.